Table S2 from Multi-omics Approach Reveals Distinct Differences in Left- and Right-Sided Colon Cancer

Wangxiong Hu,Yanmei Yang,Xiaofen Li,Minran Huang,Fei Xu,Weiting Ge,Suzhan Zhang,Shu Zheng

DOI: https://doi.org/10.1158/1541-7786.22513080.v1

2023-01-01

Abstract:Supplementary table2 Differentially methylated regions identified by bumphunter

What problem does this paper attempt to address?

Figure S1 from Multi-omics Approach Reveals Distinct Differences in Left- and Right-Sided Colon Cancer

Wangxiong Hu,Yanmei Yang,Xiaofen Li,Minran Huang,Fei Xu,Weiting Ge,Suzhan Zhang,Shu Zheng

DOI: https://doi.org/10.1158/1541-7786.22513086

2023-01-01

Abstract:IHC staining of selected LCC (A~C) and RCC (D~F) of PRAC
Comparative proteomic study for profiling differentially expressed proteins between Chinese left- and right-sided colon cancers.

Hong Shen,Jinlin Huang,Haiping Pei,Shan Zeng,Yiming Tao,Liangfang Shen,Liang Zeng,Hong Zhu

DOI: https://doi.org/10.1111/cas.12029

IF: 5.7

2013-01-01

Cancer Science

Abstract:The aim of the present study is to profile differentially expressed protein markers between left-sided colon cancer (LSCC) and right-sided colon cancer (RSCC). Fresh tumor tissue samples from LSCC (n = 7) and RSCC (n = 7) groups were analyzed by two-dimensional electrophoresis coupled with MALDI-TOF-MS, followed by Western blotting. In 50 paraffin embedded samples from each group, levels of four differentially expressed proteins (identified by proteomics analysis) were measured by tissue microarray with immunohistochemistry staining to compare the different protein markers between LSCC and RSCC. Sixteen proteins were found to be differentially expressed between LSCC and RSCC. Ten proteins including HSP-60 and PDIA1 were identified to be highly expressed in LSCC (P < 0.01 or P < 0.05), while the expression of six proteins including EEF1D and HSP-27 were higher in RSCC (P < 0.01 or P < 0.05). Virtually all of the indentified proteins were involved in cellular energy metabolism, protein folding/unfolding, and/or oxidative stress. Human colon tumors at various locations have different proteomic biomarkers. Differentially expressed proteins associated with energy metabolism, protein folding/unfolding and oxidative stress contribute to different tumorigenesis, tumor progression, and prognosis between left- and right-sided colon cancer. (Cancer Sci 2013; 104: 141135)
Supplementary Table S4 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study

Wenju Chang,Zhou Zhang,Baoqing Jia,Kefeng Ding,Zhizhong Pan,Guoqiang Su,Wei Zhang,Tianyu Liu,Yunshi Zhong,Guodong He,Li Ren,Ye Wei,Dongdong Li,Xiaolong Cui,Jun Yang,Yixiang Shi,Marc Bissonnette,Chuan He,Wei Zhang,Jia Fan,Jianmin Xu

DOI: https://doi.org/10.1158/1078-0432.26422958.v1

2024-01-01

Abstract:Differetially modified gene bodies between CRC/AA and controls.
Analysis Of Multi-Omics Differences In Left-Side And Right-Side Colon Cancer

Yanyi Huang,Jinzhong Duanmu,Yushu Liu,Mengyun Yan,Taiyuan Li,Qunguang Jiang

DOI: https://doi.org/10.7717/peerj.11433

IF: 3.061

2021-01-01

PeerJ

Abstract:Background: Colon cancer is one of the most common tumors in the digestive tract. Studies of left-side colon cancer (LCC) and right-side colon cancer (RCC) show that these two subtypes have different prognoses, outcomes, and clinical responses to chemotherapy. Therefore, a better understanding of the importance of the clinical classifications of the anatomic subtypes of colon cancer is needed.Methods: We collected colon cancer patients' transcriptome data, clinical information, and somatic mutation data from the Cancer Genome Atlas (TCGA) database portal. The transcriptome data were taken from 390 colon cancer patients (172 LCC samples and 218 RCC samples); the somatic mutation data included 142 LCC samples and 187 RCC samples. We compared the expression and prognostic differences of LCC and RCC by conducting a multi-omics analysis of each using the clinical characteristics, immune microenvironment, transcriptomic differences, and mutation differences. The prognostic signatures was validated using the internal testing set, complete set, and external testing set (GSE39582). We also verified the independent prognostic value of the signature.Results: The results of our clinical characteristic analysis showed that RCC had a significantly worse prognosis than LCC. The analysis of the immune microenvironment showed that immune infiltration was more common in RCC than LCC. The results of differential gene analysis showed that there were 360 differentially expressed genes, with 142 upregulated genes in LCC and 218 upregulated genes in RCC. The mutation frequency of RCC was generally higher than that of LCC. BRAF and KRAS gene mutations were the dominant genes mutations in RCC, and they had a strong mutual exclusion with APC, while APC gene mutation was the dominant gene mutation in LCC. This suggests that the molecular mechanisms of RCC and LCC differed. The 4-mRNA and 6-mRNA in the prognostic signatures of LCC and RCC, respectively, were highly predictive and may be used as independent prognostic factors.Conclusion: The clinical classification of the anatomic subtypes of colon cancer is of great significance for early diagnosis and prognostic risk assessment. Our study provides directions for individualized treatment of left and right colon cancer.
Microbial Community Profiling Distinguishes Left-Sided and Right-Sided Colon Cancer

Mengya Zhong,Yubo Xiong,Zhijian Ye,Jiabao Zhao,Lifeng Zhong,Yu Liu,Yuekun Zhu,Lantian Tian,Xingfeng Qiu,Xuehui Hong

DOI: https://doi.org/10.3389/fcimb.2020.498502

IF: 6.073

2020-11-26

Frontiers in Cellular and Infection Microbiology

Abstract:The difference between left- and right-sided colon cancer has become the focus of global attention, and researchers have found differences in the morbidity, molecular biological characteristics, and response to targeted drug therapy between left- and right-sided colon cancer. Therefore, the identification of more effective predictive indicators is critical for providing guidance to future clinical work. We collected samples from different colon sites and regions and analyzed the identities and distributions of differentially expressed species in the microbiota in the left and right sides of the colon to better explore the pathogenesis of colon cancer and provided a basis for individualized drug therapy. We collected samples from different regions in the body of 40 patients with colon cancer, including stool and tissues. The Subjects were classified into four groups, and this classification was mainly based on the colon cancer distribution. The microbiota composition of the left-sided and right-sided colon samples was assessed by specifically amplifying the V3-V4 region of the 16S rDNA gene from DNA extracts from the samples. These amplicons were examined by Illumina HiSeq 2500 sequencing. The microbial taxa in the left-sided colon samples are more abundant than those in the right-sided colon samples. The flora in the left-sided colon samples, such as Clostridium perfringens and Fusobacterium nucleatum , might be associated with VEGF expression and are more likely to promote colon cancer. The microbiota distribution in the right-sided colon samples is less invasive and harmful and particularly rich in Bifidobacterium dentium . In addition, Streptococcus , which is the target of EGFR, was found to be expressed in both the left- and right-sided colon samples but was found at a higher level in the left-sided colon samples. Additionally, the differential pathways involved in the left-sided colon samples mainly mediate DNA damage, methylation, and histone modifications, whereas those in the right-sided colon samples are dominated by DNA synthesis. The comparison of only the geographical differences revealed a significant difference in the distribution of the microbial population. The adherent microbiota composition and structural changes between the left- and right-sided colon samples might contribute to the development of colon cancer, lead to different morbidities, and further affect the prognosis of patients and their sensitivity to targeted drugs. Therefore, the identification of the differential flora in the colon could be used as an indicator for predicting the occurrence and development of colon cancer, which is also beneficial for future individualized drug therapy.

immunology,microbiology
Supplementary Table S3 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study

Wenju Chang,Zhou Zhang,Baoqing Jia,Kefeng Ding,Zhizhong Pan,Guoqiang Su,Wei Zhang,Tianyu Liu,Yunshi Zhong,Guodong He,Li Ren,Ye Wei,Dongdong Li,Xiaolong Cui,Jun Yang,Yixiang Shi,Marc Bissonnette,Chuan He,Wei Zhang,Jia Fan,Jianmin Xu

DOI: https://doi.org/10.1158/1078-0432.26422961.v1

2024-01-01

Abstract:Participant characteristics of 80 patients with other cancers.
Table S1 from Comparative Epigenetic Profiling Reveals Distinct Features of Mucosal Melanomas Associated with Immune Cell Infiltration and Their Clinical Implications

Jie Dai,Jia Jia,Fanshuang Zhang,Kaihua Liu,Yanfeng Xi,Pei Yuan,Lili Mao,Xue Bai,Xiaoting Wei,Bingning Wang,Jiangtao Li,Yang Xu,Ting Liu,Shuang Chang,Yang Shao,Jun Guo,Jianming Ying,Lu Si

DOI: https://doi.org/10.1158/2767-9764.25913656.v1

2024-01-01

Abstract:Supplementary Table 1. The univariate and multivariate COX analyses for OS associated DMRs in PMME patients.
Multi-omics Analysis Classifies Colorectal Cancer into Distinct Methylated Immunogenic and Angiogenic Subtypes Based on Anatomical Laterality

DOI: https://doi.org/10.1007/s13193-023-01760-6

2023-05-17

Indian Journal of Surgical Oncology

Abstract:We employed supervised machine learning algorithms to a cohort of colorectal cancer patients from the NCI to differentiate and classify the heterogenous disease based on anatomical laterality and multi-omics stratification, in a first of its kind. Multi-omics integrative analysis shows distinct clustering of left and right colorectal cancer with disentangled representation of methylome and delineation of transcriptome and genome. We present novel multi-omics findings consistent with augmented hypermethylation of genes in right CRC, epigenomic biomarkers on the right in conjunction with immune-mediated pathway signatures, and lymphocytic invasion which unlocks unique therapeutic avenues. Contrarily, left CRC multi-omics signature is found to be marked by angiogenesis, cadherins, and epithelial–mesenchymal transition (EMT). An integrated multi-omics molecular signature of RNF217-AS1 , hsa-miR-10b, and panel of FBX02 , FBX06 , FBX044 , MAD2L2 , and MIIP copy number altered genes have been found by the study. Overall survival analysis reveals genomic biomarkers ABCA13 and TTN in 852 LCRC cases, and SOX11 in 170 RCRC cases that predicts a significant survival benefit. Our study exemplifies the translational competence and robustness of machine learning in effective translational bridging of research and clinic.
Supplementary Table S3 from Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level

Yingcheng Wu,Shuaixi Yang,Jiaqiang Ma,Zechuan Chen,Guohe Song,Dongning Rao,Yifei Cheng,Siyuan Huang,Yifei Liu,Shan Jiang,Jinxia Liu,Xiaowu Huang,Xiaoying Wang,Shuangjian Qiu,Jianmin Xu,Ruibin Xi,Fan Bai,Jian Zhou,Jia Fan,Xiaoming Zhang,Qiang Gao

DOI: https://doi.org/10.1158/2159-8290.22540408

2023-01-01

Abstract:Supplementary Table S3. Differentially expressed genes between LM and CRC infiltrated MRC1+ CCL18+ macrophages & SPP1+ macrophages.
Molecular Differences between Hepatic and Extrahepatic Metastases from Left-Sided and Right-Sided Colorectal Cancer: Potential Metastatic and Prognostic Biomarkers

Meiqin Yuan,Jianfei Fang,Li Wang,Rongrong Chen,Haijun Zhong,Hongming Pan,Wangxia Lv

DOI: https://doi.org/10.23812/j.biol.regul.homeost.agents.20233711.557

2023-01-01

Journal of biological regulators and homeostatic agents

Abstract:Background: The most significant prognostic variables for colorectal cancer (CRC) are tumor sidedness and patterns of metastatic spread. However, less is known about the differences in the mutational profile of hepatic and extrahepatic metastases between left-sided and right-sided colorectal cancer. To address this knowledge gap, we sought to analyze the association between different metastatic sites and the gene mutational profiles in each population. We aimed to discover the molecular heterogeneity between these two subtypes of colorectal cancer.Methods: We retrospectively analyzed mutations from 185 colorectal cancer patients. The samples for next generation sequencing were primary colon tumor tissues. Formalin-fixed, paraffin-embedded tumor tissues were collected and deep sequencing targeting 1021 genes was conducted to analyze genomic alteration. Correlation analysis was performed by Chi-square or Fisher's exact tests.Results: A total of 185 CRC patients (132 left-sided colon cancer (LCC) and 53 right-sided colon cancer (RCC)) were analyzed. These included 60 patients with (32.4%) solitary liver metastasis (SLM) cohort, 43 patients (23.2%) with multiple liver metastases (MLM) cohort, 56 patients (30.3%) with extrahepatic metastases (EHM) cohort, and 26 patients (14.1%) without metastases (control cohort). Tumor protein 53 (TP53, 88% vs. 68%, p < 0.05) and adenomatous polyposis coli (APC, 78% vs. 58%, p < 0.05) were found to be mutated more frequently in LCC than RCC. In contrast, B-raf murine sarcoma viral oncogene homologue B (BRAF, 5% vs. 11%, p < 0.05), phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (PIK3CA, 13% vs. 23%, p < 0.05), lysine demethylase 6A (KDM6A, 1% vs. 8%, p < 0.05), FAT atypical cadherin 2 (FAT2, 2% vs. 11%, p < 0.05), and SRY-box transcription factor 9 (SOX9, 7% vs. 19%, p < 0.05) were more common in RCC patients compared with those with LCC. In LCC, APC was more frequently mutated in SLM, MLM, and control cohorts than in the EHM cohort (85% vs. 83% vs. 90% vs. 57%, p < 0.05). In RCC, the mutation frequencies of APC and PIK3CA were more significant in the SLM cohort when compared to the EHM cohort. However, a converse result was observed for the SMAD family member 4 (SMAD4) gene.Conclusions: These results demonstrate the molecular heterogeneity between hepatic and extrahepatic metastases from left- and right-sided colorectal cancer. These findings could help us better understand the mechanisms underlying tumor metastasis and reveal disparities in survival among metastatic locations.
Proteomic Profiling and Tumor Microenvironment Characterization Reveal Molecular and Immunological Hallmarks of Left-Sided and Right-Sided Colon Cancer Tumorigenesis

Zhu Hong,Tao Wang,Wei Wang,Haoren Jing,Hongzhen Tang,Mingyue Xu,Chaohu Pan,Xiaojing Mu,Di Zhang,Guochao Gao,Zihe Gao,Haitao Luo,Yi Zhou

DOI: https://doi.org/10.1021/acs.jproteome.3c00302

2023-09-01

Abstract:Left-sided and right-sided colon cancer (LSCC and RSCC) display different biological and clinical characteristics. However, the differences in their tumorigenesis and tumor microenvironment remain unclear. In this study, we profiled the proteomic landscapes of LSCC and RSCC with data-independent acquisition mass spectrometry (DIA-MS) using fresh tumor and adjacent normal tissues from 24 patients. A total of 7403 proteingroups were primarily identified with DIA-MS. After quality control, 7212 proteingroups were used for further analysis. Through comparing the difference in proteomic profiles between LSCC and RSCC samples, 2556 commonly and 1982 region-type-specific regulated proteingroups were characterized. During the development of LSCC and RSCC, metabolic, growth, cell division, cell adhesion, and migration pathways were found to be significantly dysregulated (P < 0.05), which was further confirmed by transcriptome data from TCGA. Compared to RSCC, most parts of the immune-related signatures, immune cell infiltration scores, and overall immune scores of LSCC were higher. The systematic elucidation of proteomic and transcriptomic profiles in this work improves our understanding of tumorigenesis and immune microenvironment characteristics of LSCC and RSCC.
Distinguishable Prognostic Signatures of Left- and Right-Sided Colon Cancer: a Study Based on Sequencing Data

Liang,Jiang-hui Zeng,Xin-gan Qin,Jun-qiang Chen,Dian-zhong Luo,Gang Chen

DOI: https://doi.org/10.1159/000491778

2018-01-01

Cellular Physiology and Biochemistry

Abstract:Background/Aims: Left- and right-sided colon cancers are considered to be two different diseases and have altered outcomes. However, specific molecules to predict the prognosis of left- and right-sided colon cancers are currently lacking. Methods: Expression profiling of colon cancer were downloaded from The Cancer Genome Atlas (TCGA). Differentially expressed genes (DEGs) of left- and right-sided colon cancers were compared by DESeq analysis. The prognostic values of DEGs were assessed by univariate and multivariate Cox regression. Prognostic index models of two side colon cancers were conducted with prognostic values genes, respectively. Interaction of DEGs was then analyzed by the protein-protein interaction (PPI). Different biology function of two sides of colon cancer was assessed by Gene Set Enrichment Analysis (GSEA). Results: A total of 167 DEGs were identified between left- and right-sided colon cancers based on TCGA data. Using univariate COX regression analysis, five genes (PHACTR3, CKMT2, CYP2W1, ERFE, HOXC4) were related to overall survival in left-sided, and eight distinguishable genes (EREG, ERFE, HOXC6, SLC22A31, TFF1, GFI1, ZG16, RASL10B) in right-sided. Further, left-sided prognostic model was established with PHACTR3 and CKMT2 (HR=2.040; 95%CI=1.004-4.145; P=0.049). Distinguishable prognostic signature for right-sided colon cancer was established based on EREG, ERFE, GFI1, and RASL10B (HR=3.530; 95%CI: 1.934-6.444; P< 0.001) in multivariate analysis. PPI analysis of 167 DEGs showed that CCL5, GNG4, GNLY, GZMH, DRD2, and FASLG genes were at the core of interaction network. In GSEA function analysis, four pathways, including antigen processing and presentation, natural killer cell mediated cytotoxicity, intestinal immune network for Iga production, and type I diabetes mellitus, were significantly enriched in the DEGs of the right-sided colon cancer. Conclusions: This study constructs a panel of potential prognostic model of left- and right-sided colon cancers, respectively. We also provide molecular biological alterations between left- and right-sided colon cancers.
Discovering the molecular differences between right- and left-sided colon cancer using machine learning methods

Yimei Jiang,Xiaowei Yan,Kun Liu,Yiqing Shi,Changgang Wang,Jiele Hu,You Li,Qinghua Wu,Ming Xiang,Ren Zhao

DOI: https://doi.org/10.1186/s12885-020-07507-8

IF: 4.638

2020-10-19

BMC Cancer

Abstract:Abstract Background In recent years, the differences between left-sided colon cancer (LCC) and right-sided colon cancer (RCC) have received increasing attention due to the clinicopathological variation between them. However, some of these differences have remained unclear and conflicting results have been reported. Methods From The Cancer Genome Atlas (TCGA), we obtained RNA sequencing data and gene mutation data on 323 and 283 colon cancer patients, respectively. Differential analysis was firstly done on gene expression data and mutation data between LCC and RCC, separately. Machine learning (ML) methods were then used to select key genes or mutations as features to construct models to classify LCC and RCC patients. Finally, we conducted correlation analysis to identify the correlations between differentially expressed genes (DEGs) and mutations using logistic regression (LR) models. Results We found distinct gene mutation and expression patterns between LCC and RCC patients and further selected the 30 most important mutations and 17 most important gene expression features using ML methods. The classification models created using these features classified LCC and RCC patients with high accuracy (areas under the curve (AUC) of 0.8 and 0.96 for mutation and gene expression data, respectively). The expression of PRAC1 and BRAF V600E mutation (rs113488022) were the most important feature for each model. Correlations of mutations and gene expression data were also identified using LR models. Among them, rs113488022 was found to have significance relevance to the expression of four genes, and thus should be focused on in further study. Conclusions On the basis of ML methods, we found some key molecular differences between LCC and RCC, which could differentiate these two groups of patients with high accuracy. These differences might be key factors behind the variation in clinical features between LCC and RCC and thus help to improve treatment, such as determining the appropriate therapy for patients.

oncology
Table S2 from Comparative Epigenetic Profiling Reveals Distinct Features of Mucosal Melanomas Associated with Immune Cell Infiltration and Their Clinical Implications

Jie Dai,Jia Jia,Fanshuang Zhang,Kaihua Liu,Yanfeng Xi,Pei Yuan,Lili Mao,Xue Bai,Xiaoting Wei,Bingning Wang,Jiangtao Li,Yang Xu,Ting Liu,Shuang Chang,Yang Shao,Jun Guo,Jianming Ying,Lu Si

DOI: https://doi.org/10.1158/2767-9764.25913653

2024-01-01

Abstract:Supplementary Table 2. The immune-related pathways that were enriched in PMME when compared with NEMM using GSEA analysis.
Abstract 5744: Characterization of sideness-related differentiated genetic alterations in stage I-IV colorectal cancer patients by using whole exome sequencing

Danyi Wang,Lee McDaniel,Sean Boyle,Giuseppe Locatelli,Juergen Scheuenpflug,Zheng Feng

DOI: https://doi.org/10.1158/1538-7445.am2022-5744

IF: 11.2

2022-06-17

Cancer Research

Abstract:Background: Although constituting a single organ, the right colon and left colon arise from midgut and hindgut embryonic precursors respectively. In the context of these embryonic origins, tumor laterality has been associated with differential microsatellite instability (MSI), aneuploidic karyotype, and loss of heterozygosity between the left and right colon. Differential genetic mutation profiles are not fully characterized in the context of left vs right laterality colorectal cancer (CRC). Therefore, we investigated associations between CRC anatomical site and somatic gene mutation patterns using whole exome sequencing. Methods: Whole exome sequencing data were collected from 55 FFPE samples from different stages (stage I: 11, II: 9; III: 19, IV: 16), treatment-naive CRC patients using the Personalis® tumor-only ImmunoID NeXT Platform®, which captures somatic mutations (SNVs), copy number variants (CNVs), percent MSI in the exome, oncovirus detection, etc. The R package maftools was used to identify differential rates of mutation between samples resected from the rectum, left, and right colon respectively. Maftools-derived mutated gene lists, filtered to p 1, were assessed for pathway enrichment with Enrichr. Results: APC and TP53 were the most commonly mutated genes in the entire cohort, with mutations seen in >90% (APC) and >75% (TP53) of samples respectively. Individual gene mutation frequency was not significantly different among the primary tumor locations (left colon; right colon; rectum) after Bonferroni multiple test correction, with FBXW7, APC, trending towards differential mutation between right colon tumors and left/rectal tumors. Maftools-derived mutated gene lists, filtered to p 1, were processed with Enrichr, identifying an enrichment of estrogen-related mutation events in right-sided vs rectal tumors (n=81 genes; Bioplanet 2019; q=5x10-4; WikiPathway 2021 Human; q<5x10-6). In rectal tumors compared to right side, PI3K/AKT signaling mutations were more enriched (n=106 genes; Kyoto Encyclopedia of Genes and Genomes 2021; q<4x10-6; MSigDB Hallmark 2020; q=9x10-3). Conclusion: A statistically significant increase in frequencies of estrogen pathway gene mutations on right-sided tumors, and on PI3K/AKT mutations on rectal tumors, were identified. These are consistent with prior expression-based findings indicating the association of estrogen signaling with right-sided tumors, and increased AKT expression with left-sided CRCs. The whole exome sequencing based laterality associated genetic mutation results provided clinically applicable evidence that patients suffered from left versus right CRC tumors may benefit differential treatment therapies, and further investigation is ongoing to explore the potential correlation between tumor laterality and stage. Citation Format: Danyi Wang, Lee McDaniel, Sean Boyle, Giuseppe Locatelli, Juergen Scheuenpflug, Zheng Feng. Characterization of sideness-related differentiated genetic alterations in stage I-IV colorectal cancer patients by using whole exome sequencing [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl) nr 5744.

oncology
Multi-omics analysis reveals the landscape of tumor microenvironments in left-sided and right-sided colon cancer

Dongfang Liu,Chen Li,Zenghua Deng,Nan Luo,Wenxia Li,Wenzhe Hu,Xiang Li,Zichao Qiu,Jianfei Chen,Jirun Peng

DOI: https://doi.org/10.3389/fmed.2024.1403171

2024-08-29

Abstract:Background: Distinct clinical features and molecular characteristics of left-sided colon cancer (LCC) and right-sided colon cancer (RCC) suggest significant variations in their tumor microenvironments (TME). These differences can impact the efficacy of immunotherapy, making it essential to investigate and understand these disparities. Methods: We conducted a multi-omics analysis, including bulk RNA sequencing (bulk RNA-seq), single-cell RNA sequencing (scRNA-seq), and whole-exome sequencing (WES), to investigate the constituents and characteristic differences of the tumor microenvironment (TME) in left-sided colon cancer (LCC) and right-sided colon cancer (RCC). Result: Deconvolution algorithms revealed significant differences in infiltrated immune cells between left-sided colon cancer (LCC) and right-sided colon cancer (RCC), including dendritic cells, neutrophils, natural killer (NK) cells, CD4 and CD8 T cells, and M1 macrophages (P < 0.05). Notably, whole-exome sequencing (WES) data analysis showed a significantly higher mutation frequency in RCC compared to LCC (82,187/162 versus 18,726/115, P < 0.01). Single-cell analysis identified predominant tumor cell subclusters in RCC characterized by heightened proliferative potential and increased expression of major histocompatibility complex class I molecules. However, the main CD8 + T cell subpopulations in RCC exhibited a highly differentiated state, marked by T cell exhaustion and recent activation, defined as tumor-specific cytotoxic T lymphocytes (CTLs). Immunofluorescence and flow cytometry results confirmed this trend. Additionally, intercellular communication analysis demonstrated a greater quantity and intensity of interactions between tumor-specific CTLs and tumor cells in RCC. Conclusion: RCC patients with an abundance of tumor-specific cytotoxic T lymphocytes (CTLs) and increased immunogenicity of tumor cells in the TME may be better candidates for immune checkpoint inhibitor therapy.
Distinctive multicellular immunosuppressive hubs confer different intervention strategies for left- and right-sided colon cancers

Bingxin Liu,Shuwei Li,Yifei Cheng,Peng Song,Menghuan Xu,Zhengyi Li,Wei Shao,Junyi Xin,Zan Fu,Dongying Gu,Mulong Du,Zhengdong Zhang,Meilin Wang

DOI: https://doi.org/10.1016/j.xcrm.2024.101589

2024-06-18

Abstract:Primary colon cancers arising from the left and right sides exhibit distinct clinical and molecular characteristics. Sidedness-associated heterogeneity relies intricately on the oncogenic properties of cancer cells and multicellular interactions in tumor microenvironments. Here, combining transcriptomic profiling of 426,863 single cells from 105 colon cancer patients and validation with spatial transcriptomics and large-scale histological analysis, we capture common transcriptional heterogeneity patterns between left- and right-sided malignant epithelia through delineating two side-specific expression meta-programs. The proliferation stemness meta-program is notably enriched in left-sided malignant epithelia that colocalize with Mph-PLTP cells, activated regulatory T cells (Tregs), and exhausted CD8-LAYN cells, constituting the glucose metabolism reprogramming niche. The immune secretory (IS) meta-program exhibits specific enrichment in right-sided malignant epithelia, especially in smoking patients with right-sided colon cancer. The IShigh malignant epithelia spatially localize in hypoxic regions and facilitate immune evasion through attenuating Mph-SPP1 cell antigen presentation and recruiting innate-like cytotoxicity-reduced CD8-CD161 cells.
Supplementary Table 2 from Single-Cell Chromatin Accessibility Analysis Reveals the Epigenetic Basis and Signature Transcription Factors for the Molecular Subtypes of Colorectal Cancers

Zhenyu Liu,Yuqiong Hu,Haoling Xie,Kexuan Chen,Lu Wen,Wei Fu,Xin Zhou,Fuchou Tang

DOI: https://doi.org/10.1158/2159-8290.25956957

2024-01-01

Abstract:Supplementary Table 2. Quality metrics, cell type annotation, and patient composition of each epithelium cluster.
Supplementary Tables 1-5 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Lingling Li,Dongxian Jiang,Hui Liu,Chunmei Guo,Qiao Zhang,Xuedong Li,Xiaojian Chen,Zheqi Chen,Jinwen Feng,Subei Tan,Wen Huang,Jie Huang,Chen Xu,Chen-Ying Liu,Wei Yu,Yingyong Hou,Chen Ding

DOI: https://doi.org/10.1158/0008-5472.26934664.v1

2024-01-01

Abstract:Supplementary tables of the revised manuscript.
Table S2 from Transcriptome-wide Landscape of Pre-mRNA Alternative Splicing Associated with Metastatic Colonization

Zhixiang Lu,Alex Q. Huang,Juw Won Park,Shihao Shen,Lin Liu,Collin Tokheim,Michael D. Henry,Yi Xing

DOI: https://doi.org/10.1158/1541-7786.22513687

2023-01-01

Abstract:Table S2. Differential AS events between PC-3E and GS689.Li

Table S2 from Multi-omics Approach Reveals Distinct Differences in Left- and Right-Sided Colon Cancer

Figure S1 from Multi-omics Approach Reveals Distinct Differences in Left- and Right-Sided Colon Cancer

Comparative proteomic study for profiling differentially expressed proteins between Chinese left- and right-sided colon cancers.

Supplementary Table S4 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study

Analysis Of Multi-Omics Differences In Left-Side And Right-Side Colon Cancer

Microbial Community Profiling Distinguishes Left-Sided and Right-Sided Colon Cancer

Supplementary Table S3 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study

Table S1 from Comparative Epigenetic Profiling Reveals Distinct Features of Mucosal Melanomas Associated with Immune Cell Infiltration and Their Clinical Implications

Multi-omics Analysis Classifies Colorectal Cancer into Distinct Methylated Immunogenic and Angiogenic Subtypes Based on Anatomical Laterality

Supplementary Table S3 from Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level

Molecular Differences between Hepatic and Extrahepatic Metastases from Left-Sided and Right-Sided Colorectal Cancer: Potential Metastatic and Prognostic Biomarkers

Proteomic Profiling and Tumor Microenvironment Characterization Reveal Molecular and Immunological Hallmarks of Left-Sided and Right-Sided Colon Cancer Tumorigenesis

Distinguishable Prognostic Signatures of Left- and Right-Sided Colon Cancer: a Study Based on Sequencing Data

Discovering the molecular differences between right- and left-sided colon cancer using machine learning methods

Table S2 from Comparative Epigenetic Profiling Reveals Distinct Features of Mucosal Melanomas Associated with Immune Cell Infiltration and Their Clinical Implications

Abstract 5744: Characterization of sideness-related differentiated genetic alterations in stage I-IV colorectal cancer patients by using whole exome sequencing

Multi-omics analysis reveals the landscape of tumor microenvironments in left-sided and right-sided colon cancer

Distinctive multicellular immunosuppressive hubs confer different intervention strategies for left- and right-sided colon cancers

Supplementary Table 2 from Single-Cell Chromatin Accessibility Analysis Reveals the Epigenetic Basis and Signature Transcription Factors for the Molecular Subtypes of Colorectal Cancers

Supplementary Tables 1-5 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Table S2 from Transcriptome-wide Landscape of Pre-mRNA Alternative Splicing Associated with Metastatic Colonization